Key Takeaways
- Mounjaro® and Zepbound® are two of the most talked-about weight loss medications right now, but many people aren't quite sure what they actually do.
- Both medications contain tirzepatide, which works by targeting two hormonal pathways — GLP-1 and GIP — that regulate appetite, digestion, and blood sugar.
- Tirzepatide is distinct from earlier GLP-1 medications because of this dual-hormone mechanism, which contributes to its particularly strong clinical results.
- Most patients don't experience dramatic side effects, but knowing what to expect during treatment helps set realistic expectations.
- Results vary based on individual factors, and outcomes are significantly better when medication is combined with sustainable lifestyle changes.
- TrueCare Medical offers medical weight loss treatment with Mounjaro® and Zepbound® in Lilburn and Suwanee, GA.
What GLP-1 Hormones Are and What They Normally Do
Before getting into how Mounjaro and Zepbound work, it helps to understand the hormonal system they're built around.
GLP-1 stands for glucagon-like peptide-1. It's a hormone produced naturally in the small intestine and released after you eat a meal. When GLP-1 is released, several things happen:
- It signals to your brain that you're full and it's time to stop eating.
- It slows gastric emptying — the rate at which food moves from your stomach into your small intestine — keeping you feeling full longer.
- It stimulates the pancreas to release insulin in response to rising blood sugar.
- It suppresses glucagon, a hormone that raises blood sugar levels.
Together, these effects help regulate appetite, portion control, and blood sugar after meals. In people with obesity, this GLP-1 signaling system is often blunted — the 'I'm full' message doesn't come through as strongly as it should, making it harder to stop eating at the right time.
GIP stands for glucose-dependent insulinotropic polypeptide. Like GLP-1, it's a gut hormone released after eating that helps regulate insulin secretion and plays a role in energy balance. Research suggests that activating the GIP pathway alongside GLP-1 enhances the weight loss effect beyond what either hormone achieves on its own.
How Mounjaro and Zepbound Mimic and Amplify These Hormones
Tirzepatide — the active ingredient in both Mounjaro® and Zepbound® — is a synthetic molecule designed to bind to and activate both the GLP-1 and GIP receptors simultaneously. This is what sets tirzepatide apart from earlier GLP-1 receptor agonists like semaglutide (the active ingredient in Wegovy® and Ozempic®), which only target the GLP-1 pathway.
By activating both receptors at once, tirzepatide:
- Reduces appetite more effectively than GLP-1 alone
- Slows digestion so you feel full longer after smaller amounts of food
- Improves insulin sensitivity and blood sugar regulation
- Reduces fat storage, particularly visceral fat (the fat stored around organs)
The clinical results have been notable. In the SURMOUNT-1 trial published in the New England Journal of Medicine, adults with obesity who received the highest dose of tirzepatide lost an average of about 20% of their body weight over 72 weeks — significantly more than what was observed with GLP-1-only medications in comparable studies.
What Makes Tirzepatide Different from Earlier GLP-1 Medications
The distinction between tirzepatide and earlier GLP-1 medications is worth understanding, particularly for patients who may have tried other options without achieving the results they hoped for.
| Feature | GLP-1 Only (e.g., Semaglutide) | Tirzepatide (Mounjaro / Zepbound) |
|---|---|---|
| Hormonal targets | GLP-1 receptor | GLP-1 + GIP receptors |
| Appetite reduction | Significant | Very significant |
| Average weight loss in trials | ~10–15% of body weight | ~15–22% of body weight |
| Blood sugar regulation | Strong | Very strong |
| Administration | Weekly injection | Weekly injection |
| FDA approval for weight loss | Wegovy® (semaglutide) | Zepbound® (tirzepatide) |
It's important to note that individual results vary significantly based on starting weight, lifestyle habits, how the medication is dosed, and how long treatment continues. Your provider at TrueCare Medical will set realistic expectations with you during your consultation.
What Typical Treatment Looks Like — From Injection to Follow-Up
Tirzepatide is administered as a once-weekly subcutaneous injection, meaning it's injected under the skin — typically in the abdomen, thigh, or upper arm — using a small pen device that most patients find manageable after a brief learning curve.
Here's what the treatment experience generally looks like:
- Starting dose: Treatment begins at a low starting dose, typically 2.5 mg per week, to allow your body to adjust and minimize the risk of side effects.
- Dose escalation: Every four weeks, the dose is gradually increased. Most patients work up to a maintenance dose over several months, with the goal of reaching the dose that produces results while remaining well tolerated.
- Common early side effects: The most frequently reported side effects are gastrointestinal — nausea, mild stomach discomfort, and occasional vomiting — and tend to be most noticeable in the first few weeks of treatment or after a dose increase. For most patients, these symptoms improve over time and are manageable when they follow provider guidance on eating smaller, more frequent meals.
- Follow-up appointments: Regular check-ins with your provider at TrueCare Medical allow the team to monitor your progress, adjust your dose if needed, and address any concerns. This ongoing relationship is an important part of what makes medical weight loss treatment different from picking up a medication and going it alone.
- Lifestyle habits: Tirzepatide works best — and produces the most durable results — when paired with meaningful changes to eating habits and physical activity levels. The medication reduces hunger and makes it easier to eat less, but building sustainable habits creates the foundation for keeping the weight off long-term.
What Realistic Results Look Like — and What Influences Them
Clinical trial data gives a population-level picture of what tirzepatide can do, but individual results vary. Factors that influence how much weight someone loses on tirzepatide include:
- Starting body weight — Patients with higher starting weights may see larger absolute weight reductions.
- Dose reached — Higher doses are associated with greater weight loss, which is why dose escalation is built into the protocol.
- Dietary habits — Tirzepatide makes it easier to eat less, but continuing to consume a high-calorie, high-sodium diet limits how much the medication can do.
- Physical activity — Exercise doesn't just burn calories; it helps preserve muscle mass during weight loss, which matters for long-term metabolic health.
- Consistency — Like most medications, tirzepatide works best when taken consistently and as directed.
- Duration of treatment — Most of the significant weight loss observed in trials occurred over 12 to 18 months of continuous treatment.
At TrueCare Medical, the team takes a thorough, individualized approach to medical weight loss treatment. That means starting with a full evaluation of your health history and goals, having an honest conversation about what's realistic for your situation, and being there throughout the process to support your progress.
Find Out If Mounjaro or Zepbound Is Right for You
If you're curious about tirzepatide and whether it might be a good fit for your weight loss goals, the best next step is a consultation with a provider who can evaluate your full health picture. TrueCare Medical offers medical weight loss services at our Lilburn and Suwanee, GA locations, including access to Mounjaro® and Zepbound® with personalized, medically supervised care.
Contact TrueCare Medical today to discuss your weight loss goals and learn what tirzepatide treatment involves.
Frequently Asked Questions
What is the difference between Mounjaro and Zepbound?
Mounjaro® and Zepbound® both contain the same active ingredient — tirzepatide — and work identically in the body. The difference is their approved use: Mounjaro is FDA-approved for the treatment of type 2 diabetes, while Zepbound is FDA-approved specifically for chronic weight management in adults with obesity or overweight with a related health condition. Your provider will help determine which is appropriate based on your health profile.
How does tirzepatide work for weight loss?
Tirzepatide activates both GLP-1 and GIP receptors — two hormonal pathways that regulate hunger, fullness, and blood sugar. By mimicking and amplifying these hormones, it reduces appetite, slows digestion, and makes it significantly easier to eat less without feeling deprived. It also improves insulin sensitivity, which supports healthier blood sugar levels alongside weight loss.
What side effects should I expect from Mounjaro or Zepbound?
The most common side effects are gastrointestinal: nausea, upset stomach, and occasionally vomiting. These tend to be most pronounced early in treatment and after dose increases, and they typically improve as your body adjusts. Starting at a low dose and gradually escalating is specifically designed to minimize these effects. Your provider can also offer guidance on eating habits that reduce nausea during the early weeks.
How long does it take to see results with tirzepatide?
Most patients begin to notice appetite reduction and early weight loss within the first few weeks. More significant results tend to build over several months as the dose is gradually increased. Clinical trials showed the most substantial weight loss occurring over the course of 12 to 18 months of treatment. Results vary based on individual factors, and your provider will track your progress at regular follow-up appointments.
Where can I find a medical weight loss clinic near me?
TrueCare Medical offers medical weight loss services including tirzepatide treatment at both our Lilburn and Suwanee locations. Request an appointment online or call us at (678) 369-9399.
